31 related articles for article (PubMed ID: 24368529)
1. Imaging in neuro-oncology.
Nandu H; Wen PY; Huang RY
Ther Adv Neurol Disord; 2018; 11():1756286418759865. PubMed ID: 29511385
[TBL] [Abstract][Full Text] [Related]
2. Macrophages as a potential tumor-microenvironment target for noninvasive imaging of early response to anticancer therapy.
Cao Q; Yan X; Chen K; Huang Q; Melancon MP; Lopez G; Cheng Z; Li C
Biomaterials; 2018 Jan; 152():63-76. PubMed ID: 29111494
[TBL] [Abstract][Full Text] [Related]
3. An Update on the Approach to the Imaging of Brain Tumors.
Mullen KM; Huang RY
Curr Neurol Neurosci Rep; 2017 Jul; 17(7):53. PubMed ID: 28516376
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography of high-grade gliomas.
Frosina G
J Neurooncol; 2016 May; 127(3):415-25. PubMed ID: 26897013
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.
Huang RY; Neagu MR; Reardon DA; Wen PY
Front Neurol; 2015; 6():33. PubMed ID: 25755649
[TBL] [Abstract][Full Text] [Related]
6. How treatment monitoring is influencing treatment decisions in glioblastomas.
Neagu MR; Huang RY; Reardon DA; Wen PY
Curr Treat Options Neurol; 2015 Apr; 17(4):343. PubMed ID: 25749847
[TBL] [Abstract][Full Text] [Related]
7. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.
Barwick T; Bencherif B; Mountz JM; Avril N
Nucl Med Commun; 2009 Dec; 30(12):908-17. PubMed ID: 19794320
[TBL] [Abstract][Full Text] [Related]
8. A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients.
Bollineni VR; Kramer GM; Jansma EP; Liu Y; Oyen WJ
Eur J Cancer; 2016 Mar; 55():81-97. PubMed ID: 26820682
[TBL] [Abstract][Full Text] [Related]
9. Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
Corroyer-Dulmont A; Pérès EA; Gérault AN; Savina A; Bouquet F; Divoux D; Toutain J; Ibazizène M; MacKenzie ET; Barré L; Bernaudin M; Petit E; Valable S
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):682-94. PubMed ID: 26537287
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Nedergaard MK; Michaelsen SR; Perryman L; Erler J; Poulsen HS; Stockhausen MT; Lassen U; Kjaer A
Nucl Med Biol; 2016 Mar; 43(3):198-205. PubMed ID: 26924500
[TBL] [Abstract][Full Text] [Related]
11. Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
Brahm CG; den Hollander MW; Enting RH; de Groot JC; Solouki AM; den Dunnen WFA; Heesters MAAM; Wagemakers M; Verheul HMW; de Vries EGE; Pruim J; Walenkamp AME
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2404-2412. PubMed ID: 30032322
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH
J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925
[TBL] [Abstract][Full Text] [Related]
13. 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Reardon DA; Coleman RE
Mol Imaging Biol; 2006; 8(6):340-7. PubMed ID: 17051323
[TBL] [Abstract][Full Text] [Related]
14. Assessment of early therapy response with 18F-FLT PET in glioblastoma multiforme.
Oborski MJ; Demirci E; Laymon CM; Lieberman FS; Mountz JM
Clin Nucl Med; 2014 Oct; 39(10):e431-2. PubMed ID: 24368529
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
